bioRxiv · 10.1101/2025.09.17.676934
Potent broad-spectrum anti-coronaviral frameshift inhibitors from virtual screen of RNA binding
Abstract
Coronavirus genomes contain an RNA pseudoknot that directs -1 programmed ribosomal frame-shifting (-1 PRF) to control expression of viral proteins crucial for replication. Ligands that inhibit -1 PRF can thus attenuate viral propagation and have potential as drugs for limiting corona-virus infections. To search for novel small-molecule frameshift inhibitors with anticoronaviral activity, we computationally screened over 14 million compounds for binding to the SARS-CoV-2 pseudoknot, followed by experimental validation of the top hits for inhibition of -1 PRF and viral replication. We identified multiple potent -1 PRF inhibitors, effective at nM concentrations, some of which significantly suppressed SARS-CoV-2 replication in cell culture. Several compounds also inhibited -1 PRF in multiple representative bat coronaviruses, indicating broad-spectrum activity. These results showcase the promise of viral RNA structures like frameshift-stimulatory pseudoknots as targets for broad-spectrum antiviral drugs.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Neupane, K., Sekar, R. V., Ileperuma, S. M., Reklow, E., Munshi, S., Omar, S. I., Arbabimoghadam, S., Peterson, J. A., Tuszynski, J. A., Hobman, T. C., Woodside, M. T.. 2025-09-18. Potent broad-spectrum anti-coronaviral frameshift inhibitors from virtual screen of RNA binding. https://doi.org/10.1101/2025.09.17.676934
Cite the original work for its findings. Save a collection to share your selection of sources.